Web17 mar 2024 · Company. Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapeutics. The Company's lead product candidate, TP-03, is an investigational eye drop in Phase III to treat blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Web102 righe · 27 mar 2024 · Tarsus Pharmaceuticals, Inc. (TARS) NasdaqGS - NasdaqGS …
Tarsus Connect LLC - Company Profile and News - Bloomberg …
Web3 mag 2024 · IRVINE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) (the ... Tarsus Announces Pricing of Upsized $75.6 Million Underwritten Public Offering of Common Stock. Web31 mar 2024 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Tarsus Pharmaceuticals stock is Buy based on the current 2 buy ratings for … thd creme
TARSUS PHARMACEUTICALS, INC. : TARS Stock Price
WebStock analysis for Tarsus Pharmaceuticals Inc (TARS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Web6 apr 2024 · Tarsus Pharmaceuticals - TARS - Stock Price Today - Zacks Tarsus Pharmaceuticals (TARS) (Delayed Data from NSDQ) $12.57 USD +0.34 (2.78%) … Web7 feb 2024 · Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Stock Price, Quote, News & History Nasdaq MY QUOTES: TARS Edit my quotes Tarsus Pharmaceuticals, … thd cream emorroidi 30ml